COVID-19 Vaccine Market (Vaccine Type: mRNA, Viral Vector Vaccines (Adenovirus Vaccines, Inactivated Virus Vaccines, and Others), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Jan 2023| TMR3540A| Transparency

Report Highlights

COVID-19 Vaccine Market – Scope of Report
TMR’s report on the global COVID-19 vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global COVID-19 vaccine market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global COVID-19 vaccine market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the COVID-19 vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global COVID-19 vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global COVID-19 vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global COVID-19 vaccine market.

The report delves into the competitive landscape of the global COVID-19 vaccine market. Key players operating in the global COVID-19 vaccine market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global COVID-19 vaccine market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market COVID-19 vaccine.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
    • WorldWideScience.org
    • Elsevier, Inc.
    • National Institutes of Health (NIH)
    • PubMed
    • NCBI
    • Department of Health Care Service
  • Trade Data Sources
    • Trade Map
    • UN Comtrade
    • Trade Atlas
  • Company Information
    • OneSource Business Browser
    • Hoover’s
    • Factiva
    • Bloomberg
  • Mergers & Acquisitions
    • Thomson Mergers & Acquisitions
    • MergerStat
    • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

 

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2031
Growth rate -13.60%
Units considered $ Million
Segments covered By Viral Vector Vaccines, By Vaccine Type, By Age Group, By mRNA, By Distribution Channel, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Companies studied
  • Pfizer-BioNTech,
  • Sinovac,
  • Moderna,
  • AstraZeneca,
  • Johnson & Johnson,
  • Sinopharm,
  • Serum Institute of India,
  • Bharat Biotech,
  • Gamaleya Research Institute,
  • Novavax, and others

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2017–2031
  • Table 2 : Global COVID-19 Vaccine Market Value (US$ Mn) Forecast, by mRNA, 2017–2031
  • Table 3 : Global COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Viral Vector Vaccines, 2017–2031
  • Table 4 : Global COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
  • Table 5 : Global COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 6 : Global COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 7 : North America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2017–2031
  • Table 8 : North America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by mRNA, 2017–2031
  • Table 9 : North America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Viral Vector Vaccines, 2017–2031
  • Table 10 : North America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
  • Table 11 : North America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 12 : North America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 13 : Europe COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type , 2017–2031
  • Table 14 : Europe COVID-19 Vaccine Market Value (US$ Mn) Forecast, by mRNA, 2017–2031
  • Table 15 : Europe COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Viral Vector Vaccines, 2017–2031
  • Table 16 : Europe COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
  • Table 17 : Europe COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 18 : Europe COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
  • Table 19 : Asia Pacific COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2017–2031
  • Table 20 : Asia Pacific COVID-19 Vaccine Market Value (US$ Mn) Forecast, by mRNA, 2017–2031
  • Table 21 : Asia Pacific COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Viral Vector Vaccines, 2017–2031
  • Table 22 : Asia Pacific COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
  • Table 23 : Asia Pacific COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 24 : Asia Pacific COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
  • Table 25 : Latin America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2017–2031
  • Table 26 : Latin America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by mRNA, 2017–2031
  • Table 27 : Latin America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Viral Vector Vaccines, 2017–2031
  • Table 28 : Latin America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
  • Table 29 : Latin America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 30 : Latin America COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
  • Table 31 : Middle East & Africa COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2017–2031
  • Table 32 : Middle East & Africa COVID-19 Vaccine Market Value (US$ Mn) Forecast, by mRNA, 2017–2031
  • Table 33 : Middle East & Africa COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Viral Vector Vaccines, 2017–2031
  • Table 34 : Middle East & Africa COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
  • Table 35 : Middle East & Africa COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 36 : Middle East & Africa COVID-19 Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
  • Figure 1 : Global COVID-19 Vaccine Market
  • Figure 2 : Global COVID-19 Vaccine Market Size (US$ Mn) Forecast, 2017–2031
  • Figure 3 : Market Value Share, by Vaccine Type (2021)
  • Figure 4 : Market Value Share, by Age Group (2021)
  • Figure 5 : Market Value Share, by Distribution Channel (2021)
  • Figure 6 : Market Value Share, by Region (2021)
  • Figure 7 : Global COVID-19 Vaccine Market Value Share, by Vaccine Type, 2021 and 2031
  • Figure 8 : Global COVID-19 Vaccine Market Attractiveness, by Vaccine Type , 2021–2031
  • Figure 9 : Global COVID-19 Vaccine Market Value Share, by Age Group, 2021 and 2031
  • Figure 10 : Global COVID-19 Vaccine Market Attractiveness, by Age Group, 2021–2031
  • Figure 11 : Global COVID-19 Vaccine Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 12 : Global COVID-19 Vaccine Market Attractiveness, by Distribution Channel, 2021–2031
  • Figure 13 : Global COVID-19 Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
  • Figure 14 : Global COVID-19 Vaccine Market Value Share, by Region, 2021–2031
  • Figure 15 : Global COVID-19 Vaccine Market Attractiveness, by Region, 2021–2031
  • Figure 16 : North America COVID-19 Vaccine Market Value Share, by Vaccine Type, 2021 and 2031
  • Figure 17 : North America COVID-19 Vaccine Market Attractiveness, by Vaccine Type , 2021–2031
  • Figure 18 : North America COVID-19 Vaccine Market Value Share, by Age Group, 2021 and 2031
  • Figure 19 : North America COVID-19 Vaccine Market Attractiveness, by Age Group, 2021–2031
  • Figure 20 : North America COVID-19 Vaccine Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 21 : North America COVID-19 Vaccine Market Attractiveness, by Distribution Channel, 2021–2031
  • Figure 22 : North America COVID-19 Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
  • Figure 23 : North America COVID-19 Vaccine Market Value Share, by Country, 2021–2031
  • Figure 24 : North America COVID-19 Vaccine Market Attractiveness, by Country, 2021–2031
  • Figure 25 : Europe COVID-19 Vaccine Market Value Share, by Vaccine Type, 2021 and 2031
  • Figure 26 : Europe COVID-19 Vaccine Market Attractiveness, by Vaccine Type , 2021–2031
  • Figure 27 : Europe COVID-19 Vaccine Market Value Share, by Age Group, 2021 and 2031
  • Figure 28 : Europe COVID-19 Vaccine Market Attractiveness, by Age Group, 2021–2031
  • Figure 29 : Europe COVID-19 Vaccine Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 30 : Europe COVID-19 Vaccine Market Attractiveness, by Distribution Channel, 2021–2031
  • Figure 31 : Europe COVID-19 Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
  • Figure 32 : Europe COVID-19 Vaccine Market Value Share, by Country/Sub-Region, 2021–2031
  • Figure 33 : Europe COVID-19 Vaccine Market Attractiveness, by Country/Sub-Region, 2021–2031
  • Figure 34 : Asia Pacific COVID-19 Vaccine Market Value Share, by Vaccine Type, 2021 and 2031
  • Figure 35 : Asia Pacific COVID-19 Vaccine Market Attractiveness, by Vaccine Type , 2021–2031
  • Figure 36 : Asia Pacific COVID-19 Vaccine Market Value Share, by Age Group, 2021 and 2031
  • Figure 37 : Asia Pacific COVID-19 Vaccine Market Attractiveness, by Age Group, 2021–2031
  • Figure 38 : Asia Pacific COVID-19 Vaccine Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 39 : Asia Pacific COVID-19 Vaccine Market Attractiveness, by Distribution Channel, 2021–2031
  • Figure 40 : Asia Pacific COVID-19 Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
  • Figure 41 : Asia Pacific COVID-19 Vaccine Market Value Share, by Country/Sub-Region, 2021–2031
  • Figure 42 : Asia Pacific COVID-19 Vaccine Market Attractiveness, by Country/Sub-Region, 2021–2031
  • Figure 43 : Latin America COVID-19 Vaccine Market Value Share, by Vaccine Type, 2021 and 2031
  • Figure 44 : Latin America COVID-19 Vaccine Market Attractiveness, by Vaccine Type , 2021–2031
  • Figure 45 : Latin America COVID-19 Vaccine Market Value Share, by Age Group, 2021 and 2031
  • Figure 46 : Latin America COVID-19 Vaccine Market Attractiveness, by Age Group, 2021–2031
  • Figure 47 : Latin America COVID-19 Vaccine Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 48 : Latin America COVID-19 Vaccine Market Attractiveness, by Distribution Channel, 2021–2031
  • Figure 49 : Latin America COVID-19 Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
  • Figure 50 : Latin America COVID-19 Vaccine Market Value Share, by Country/Sub-Region, 2021–2031
  • Figure 51 : Latin America COVID-19 Vaccine Market Attractiveness, by Country/Sub-Region, 2021–2031
  • Figure 52 : Middle East & Africa COVID-19 Vaccine Market Value Share, by Vaccine Type, 2021 and 2031
  • Figure 53 : Middle East & Africa COVID-19 Vaccine Market Attractiveness, by Vaccine Type, 2021–2031
  • Figure 54 : Middle East & Africa COVID-19 Vaccine Market Value Share, by Age Group, 2021 and 2031
  • Figure 55 : Middle East & Africa COVID-19 Vaccine Market Attractiveness, by Age Group, 2021–2031
  • Figure 56 : Middle East & Africa COVID-19 Vaccine Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 57 : Middle East & Africa COVID-19 Vaccine Market Attractiveness, by Distribution Channel, 2021–2031
  • Figure 58 : Middle East & Africa COVID-19 Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
  • Figure 59 : Middle East & Africa COVID-19 Vaccine Market Value Share, by Country/Sub-Region, 2021–2031
  • Figure 60 : Middle East & Africa COVID-19 Vaccine Market Attractiveness, by Country/Sub-Region, 2021–2031
  • Figure 61 : Global COVID-19 Vaccine Market Share Analysis, by Company, 2021 (Estimated)
  • Figure 62 : Global COVID-19 Vaccine Market Performance, by Company, 2021
  • Figure 63 : Competition Matrix

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS